Startseite Validation of a new generation POCT glucose device with emphasis on aspects important for glycemic control in the hospital care
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Validation of a new generation POCT glucose device with emphasis on aspects important for glycemic control in the hospital care

  • Snježana Kos EMAIL logo , Arie van Meerkerk , Joke van der Linden , Theo Stiphout und Remi Wulkan
Veröffentlicht/Copyright: 16. März 2012
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: Point-of-care (POC) glucose devices are widely used for insulin-dosage decision-making although such an application is not always permitted. In this study, we have evaluated a new generation of POC glucose device, the HemoCue® Glucose 201DMRT (201DMRT), for its suitability for (tight) glycemic control.

Materials and methods: This study was performed according to the CLSI/STARD criteria. The 201DMRT was compared to the laboratory hexokinase glucose method (Siemens Dimension Vista®). The variation among different POC devices and cuvette lot numbers was examined. Additionally, the influence of the partial pressure of oxygen and hematocrit on glucose measurement was investigated.

Results: The 201DMRT showed a good agreement with the laboratory reference method. This was examined using Deming regression analysis, percentage Bland-Altman plot and a modified Clarke-error grid. The total analytical error at the clinically critical glucose concentrations of 5.6, 7.0 and 11.1 mmol/L (101, 126 and 200 mg/dL) was 6.4%, 4.3% and 3.0%, respectively. The total error among the different POC devices and among different cuvette lot numbers was <6.5%. Glucose measurements on the 201DMRT were not affected by changes in partial pressure of oxygen, whereas changes in hematocrit had influence on the results (3.4% for every 0.10 L/L change in hematocrit).

Conclusions: The 201DMRT device can be used for glycemic control based on analytical results presented. However, the clinical applicability for tight glycemic control must be confirmed in a clinical study.


Corresponding author: Dr. Snježana Kos, Clinical Chemist, Maasstad Hospital Rotterdam, MaasstadLab, Department of Clinical Chemistry, P.O. Box 9100, 3007 AC Rotterdam, The Netherlands Phone: +31 10 2912782, Fax: +31 10 2911038

Received: 2011-12-4
Accepted: 2012-2-24
Published Online: 2012-3-16
Published in Print: 2012-9-1

©2012 by Walter de Gruyter Berlin Boston

Artikel in diesem Heft

  1. Masthead
  2. Masthead
  3. Editorials
  4. Neutrophil gelatinase-associated lipocalin (NGAL): the laboratory perspective
  5. Neutrophil gelatinase-associated lipocalin (NGAL): the clinician’s perspective
  6. Serum creatinine and the search for new biomarkers of acute kidney injury (AKI): the story continues
  7. Interference of new oral anticoagulants with frequently used coagulation tests
  8. Reviews
  9. Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker of acute kidney injury: a review of the laboratory characteristics and clinical evidences
  10. Neurophil gelatinase-associated lipocalin as a new biomarker in laboratory medicine
  11. Neutrophil gelatinase-associated lipocalin as a biomarker of cardiovascular disease: a systematic review
  12. Opinion Paper
  13. Collective opinion paper on findings of the 2011 convocation of experts on laboratory quality
  14. Guidelines and Recommendations
  15. Proposals for the mitigation of the environmental impact of clinical laboratories
  16. General Clinical Chemistry and Laboratory Medicine
  17. Improvement in the performance of external quality assessment in Korean HIV clinical laboratories using unrecalcified human plasma
  18. Validation of a new generation POCT glucose device with emphasis on aspects important for glycemic control in the hospital care
  19. Evaluation of NGAL Test™, a fully-automated neutrophil gelatinase-associated lipocalin (NGAL) immunoassay on Beckman Coulter AU 5822
  20. Variation of serum and urinary neutrophil gelatinase associated lipocalin (NGAL) after strenuous physical exercise
  21. Analytic and clinical validation of a standardized cystatin C particle enhanced turbidimetric assay (PETIA) to estimate glomerular filtration rate
  22. Compensating for the influence of total serum protein in the Schwartz formula
  23. Interference of the new oral anticoagulant dabigatran with frequently used coagulation tests
  24. Testing for lupus anticoagulants – fresh or frozen?
  25. Effect of coagulation factors on discrepancies in International Normalized Ratio results between instruments
  26. Mobile Laboratory Unit: a disruptor solution for hemostasis management during major surgery. Usage in the context of face transplantation
  27. Comparison of capillary electrophoregram among heterozygous Hb Hope, Hb Hope/α-thalassemia-1 SEA type deletion and Hb Hope/β0-thalassemia
  28. Aberrant lamellar body counts noted on the Beckman Coulter Unicel DxH 800
  29. Plasma betaine concentrations correlate with plasma cortisol but not with C-reactive protein in an elderly population
  30. Determinants of the essential one-carbon metabolism metabolites, homocysteine, S-adenosylmethionine, S-adenosylhomocysteine and folate, in cerebrospinal fluid
  31. Application of a modified precipitation method for the measurement of small dense LDL-cholesterol (sd-LDL-C) in a population in southern Brazil
  32. Cancer Diagnostics
  33. BCR-ABL fusion protein detection in peripheral blood and bone marrow samples of adult precursor B-cell acute lymphoblastic leukemia patients using the flow cytometric immunobead assay
  34. Clinical and pathological features of B-cell non-Hodgkin lymphomas lacking the surface expression of immunoglobulin light chains
  35. Statistical learning confirms the diagnostic significance of the anemia panel in breast cancer
  36. Letters to the Editor
  37. Neutrophil gelatinase-associated lipocalin: comparison of the use of EDTA and heparin plasma
  38. Time- and temperature-dependent stability of troponin standard reference material 2921 in serum and plasma
  39. Triplex PCR amplicons genotyping by high resolution melting using Rotor Gene 6000 platform
  40. Effect of high RNA concentrations in real time reverse transcription quantitative polymerase chain reaction (RT-qPCR) yields
  41. Detection of differential protein expression in cerebrospinal fluid of patients with multiple sclerosis through two-dimensional differential in gel electrophoresis
  42. Phosphate inhibits calcium oxalate crystal growth and crystallization through reducing free calcium ions: a morphological analysis and calcium consumption assay
  43. Congress Abstracts
  44. 4th Slovenian Congress of Clinical Chemistry with international participation and 20th International Symposium of the Slovenian Association for Clinical Chemistry and Croatian Society of Medical Biochemists
  45. Congress of Clinical Chemistry and Laboratory Medicine / 9th Annual Meeting of the German Society for Clinical Chemistry and Laboratory Medicine (DGKL)
  46. Erratum
  47. Erratum to: Plasma betaine concentrations correlate with plasma cortisol but not with C-reactive protein in an elderly population
Heruntergeladen am 10.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2011-0900/html
Button zum nach oben scrollen